Statistics for Inovio Pharmaceuticals (id:8221 INO)

Valuation metrics

Market cap

103.62M

Enterprise value

26.41M

Trailing P/E (ttm)

-0.67

Forward P/E

-1.07

PEG ratio

-1.07

Price/Sales (ttm)

175.07

Price/Book (mrq)

0.77

Enterprise Value/Revenue

44.62

Enterprise Value/EBITDA

-0.23

Overview

Shares outstanding

26.10M

Float

23.48M

Shares short

3.50M

% Held by insiders

0.01%

% Held by institutions

0.34%

Average volume (10 days)

487.56K

Average volume (90 days)

Price summary

52-Week low

3.85

52-Week high

14.75

52-Week change

-20.88%

Beta

0.83

50-Day moving average

5.66

200-Day moving average

8.66

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

January 25th, 2024

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-32,945.87%

Operational effectiveness

Return on assets

-39.91%

Return on equity

-91.42%

Income statement

Revenue (ttm)

0.02

Revenue per share (ttm)

0.02

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-114,988,248.00

Net income to common (ttm)

-121,640,472.00

Diluted EPS (ttm)

-4.43

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

110.42M

Total cash per share (mrq)

4.25

Total debt (mrq)

12.98M

Total Debt/Equity (mrq)

13.42

Current ratio (mrq)

445.30%

Book value per share (mrq)

5.15

Cash flow

Cash flow statement

-112,355,720.00

Levered free cash flow (LFCF)

-70,594,784.00